Xeris Biopharma Holdings, Inc. (XERS)
NASDAQ·Healthcare·Biotechnology
$6.79
-0.15%
Mkt Cap $1.17B
Analyst Ratings
Buy
2
Hold
0
Sell
0
Price Target (7 analysts)
$9.00
Range $9.00 – $9.00
Implied Upside
+32.5%
Consensus $9.00 vs current $6.79
NASDAQ·Healthcare·Biotechnology
$6.79
-0.15%
Mkt Cap $1.17B
Buy
2
Hold
0
Sell
0
Price Target (7 analysts)
$9.00
Range $9.00 – $9.00
+32.5%
Consensus $9.00 vs current $6.79